Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia

Authors

  • Tomas Ripoll-Vera CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain Balearic Islands Health Research Institute (iDisBA), Inherited Cardiovascular Disease Unit, Cardiology Department, Hospital Universitari Son Espases, Edifici S, Carretera de Valldemossa 79, 07120 Palma, Illes Balears Spain Son Llatzer University Hospital, Carretera de Manacor km.4, 07198 Palma, Illes Balears, Spain
  • Jorge Alvarez-Rubio CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain Balearic Islands Health Research Institute (iDisBA), Inherited Cardiovascular Disease Unit, Cardiology Department, Hospital Universitari Son Espases, Edifici S, Carretera de Valldemossa 79, 07120 Palma, Illes Balears Spain Son Llatzer University Hospital, Carretera de Manacor km.4, 07198 Palma, Illes Balears, Spain

DOI:

https://doi.org/10.21542/gcsp.2018.26

Abstract

[first paragraph of article]

Hypertrophic cardiomyopathy (HCM) is an inherited autosomal-dominant disease with a heterogeneous clinical presentation and natural history, and is a frequent cause of sudden cardiac death (SCD) in young people. It is associated with mutations in genes coding for sarcomere proteins. In the literature, debate surrounds the genotype-phenotype correlation of individual mutations concerning establishing a prognosis according to the mutation present, which could help stratify the disease and allow appropriate genetic counselling to families.

Downloads

Published

2018-10-24

Issue

Section

Review articles